New Alzheimer's drug targets different brain protein NewsMax 17:51 Tue, 14 Jul NewsMax 17:51 Tue, 14 Jul Alzheimer's Biotech Global Health All sources
FDA approves weekly at-home injection of Leqembi for Alzheimer's patients starting treatment Medical Daily 5d Medical Daily 5d Alzheimer's FDA Biotech All sources
AAIC26: Biogen stock drops after unveiling tau-targeting ASO data Clinical Trials Arena 09:54 Thu, 16 Jul Clinical Trials Arena 09:54 Thu, 16 Jul Alzheimer's Pharma All sources
Biogen and Eisai’s Leqembi study shows nearly 83% of early Alzheimer’s patients remained stable or improved PMLiVE 08:20 Wed, 15 Jul PMLiVE 08:20 Wed, 15 Jul Alzheimer's Pharma Biotech
Biogen shares decline after detailed Diranersen Alzheimer's study data Zacks 17:02 Wed, 15 Jul Zacks 17:02 Wed, 15 Jul Alzheimer's Pharma Global Health
Formation Bio Appoints Michael Ehlers as Chief Scientific Officer and Head of R&D PR Newswire (Press Release) 14:00 Wed, 22 Jul
FDA Approves Weekly At-Home Injection of Leqembi for Alzheimer's Patients Starting Treatment Medical Daily 05:26 Tue, 21 Jul
Biogen Korea names rare disease expert Kim Chul-woong as new GM Korea Biomedical Review 07:23 Mon, 20 Jul
US biotech Biogen hires Spur Therapeutics CEO as next legal chief The Global Legal Post 11:20 Thu, 16 Jul
AAIC26: Biogen stock drops after unveiling tau-targeting ASO data Clinical Trials Arena 09:54 Thu, 16 Jul
STAT Plus: Pharmalittle: We’re reading about a Biogen Alzheimer’s drug, skyrocketing 340B drug sales, and more STAT 14:10 Wed, 15 Jul